. 2023 Sep 7;49(5):1345-1354.

doi: 10.1093/schbul/sbad082.

Shared Genetic Loci Between Schizophrenia and White Blood Cell Counts Suggest Genetically Determined Systemic Immune Abnormalities

Nils Eiel Steen^{1

2}, Zillur Rahman^{1

2}, Attila Szabo^{1

3}, Guy F L Hindley^{1

4}, Nadine Parker^{1

2}, Weiqiu Cheng^{1

2}, Aihua Lin¹, Kevin S O'Connell^{1

2}, Mashhood A Sheikh^{5

6}, Alexey Shadrin^{1

2}, Shahram Bahrami^{1

2}, Sandeep Karthikeyan^{1

2}, Eva Z Hoseth^{1

7}, Anders M Dale^{8

9

10}, Pål Aukrust^{5

6

11}, Olav B Smeland^{1

2}, Thor Ueland^{5

6

12}, Oleksandr Frei^{1

13}, Srdjan Djurovic^{14

15}, Ole A Andreassen^{1

2

3}

Affiliations

¹ NORMENT Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
² Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
³ K.G. Jebsen Centre for Neurodevelopmental Disorders, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
⁴ Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
⁵ Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
⁶ Faculty of Medicine, University of Oslo, Oslo, Norway.
⁷ Division of Mental Health, Helse Møre Romsdal HF, Kristiansund, Norway.
⁸ Department of Radiology, University of California, San Diego, La Jolla, CA, USA.
⁹ Department of Cognitive Sciences, University of California, San Diego, La Jolla, CA, USA.
¹⁰ Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
¹¹ Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
¹² K.G. Jebsen-Thrombosis Research and Expertise Center (TREC), University of Tromsø, Tromsø, Norway.
¹³ Center for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway.
¹⁴ NORMENT Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
¹⁵ Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.

PMID: 37319439
PMCID: PMC10483470
DOI: 10.1093/schbul/sbad082

Shared Genetic Loci Between Schizophrenia and White Blood Cell Counts Suggest Genetically Determined Systemic Immune Abnormalities

Nils Eiel Steen et al. Schizophr Bull. 2023.

. 2023 Sep 7;49(5):1345-1354.

doi: 10.1093/schbul/sbad082.

Authors

Affiliations

¹ NORMENT Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
² Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
³ K.G. Jebsen Centre for Neurodevelopmental Disorders, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
⁴ Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
⁵ Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
⁶ Faculty of Medicine, University of Oslo, Oslo, Norway.
⁷ Division of Mental Health, Helse Møre Romsdal HF, Kristiansund, Norway.
⁸ Department of Radiology, University of California, San Diego, La Jolla, CA, USA.
⁹ Department of Cognitive Sciences, University of California, San Diego, La Jolla, CA, USA.
¹⁰ Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
¹¹ Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
¹² K.G. Jebsen-Thrombosis Research and Expertise Center (TREC), University of Tromsø, Tromsø, Norway.
¹³ Center for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway.
¹⁴ NORMENT Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
¹⁵ Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.

PMID: 37319439
PMCID: PMC10483470
DOI: 10.1093/schbul/sbad082

Abstract

Background: Immune mechanisms are indicated in schizophrenia (SCZ). Recent genome-wide association studies (GWAS) have identified genetic variants associated with SCZ and immune-related phenotypes. Here, we use cutting edge statistical tools to identify shared genetic variants between SCZ and white blood cell (WBC) counts and further understand the role of the immune system in SCZ.

Study design: GWAS results from SCZ (patients, n = 53 386; controls, n = 77 258) and WBC counts (n = 56 3085) were analyzed. We applied linkage disequilibrium score regression, the conditional false discovery rate method and the bivariate causal mixture model for analyses of genetic associations and overlap, and 2 sample Mendelian randomization to estimate causal effects.

Study results: The polygenicity for SCZ was 7.5 times higher than for WBC count and constituted 32%-59% of WBC count genetic loci. While there was a significant but weak positive genetic correlation between SCZ and lymphocytes (rg = 0.05), the conditional false discovery rate method identified 383 shared genetic loci (53% concordant effect directions), with shared variants encompassing all investigated WBC subtypes: lymphocytes, n = 215 (56% concordant); neutrophils, n = 158 (49% concordant); monocytes, n = 146 (47% concordant); eosinophils, n = 135 (56% concordant); and basophils, n = 64 (53% concordant). A few causal effects were suggested, but consensus was lacking across different Mendelian randomization methods. Functional analyses indicated cellular functioning and regulation of translation as overlapping mechanisms.

Conclusions: Our results suggest that genetic factors involved in WBC counts are associated with the risk of SCZ, indicating a role of immune mechanisms in subgroups of SCZ with potential for stratification of patients for immune targeted treatment.

Keywords: inflammation; leucocyte; pleiotropy; polygenicity; psychosis; severe mental disorder.

PubMed Disclaimer

Conflict of interest statement

OAA is a consultant to Cortechs.ai, and has received speaker’s honorarium from Lundbeck, Sunovion, and Janssen. AMD is a founder and owner of Cortechs.ai. The other authors report no conflict of interest.

Figures

**Fig. 1.**
Venn diagrams of shared variants between traits and unique variants per trait. rg: genetic correlation estimated by MiXeR (v1.3). The traits are SCZ and (a) basophil, (b) eosinophil, (c) lymphocyte, (d) monocyte, (e) neutrophil and (f) WBC counts. Numbers of variants shown in thousands with standard error in parenthesis.

See this image and copyright information in PMC

References

1. Marder SR, Cannon TDS. Schizophrenia. N Engl J Med. 2019;381(18):1753–1761. - PubMed
1. Owen MJ, Sawa A, Mortensen PBS. Schizophrenia. Lancet. 2016;388(10039):86–97. - PMC - PubMed
1. Hjorthøj C, Stürup AE, McGrath JJ, Nordentoft M.. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4(4):295–301. - PubMed
1. Müller N. Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations. Schizophr Bull. 2018;44(5):973–982. - PMC - PubMed
1. Brown AS, Meyer U.. Maternal immune activation and neuropsychiatric illness: a translational research perspective. Am J Psychiatry. 2018;175(11):1073–1083. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

R01 EB000790/EB/NIBIB NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Shared Genetic Loci Between Schizophrenia and White Blood Cell Counts Suggest Genetically Determined Systemic Immune Abnormalities

Affiliations

Shared Genetic Loci Between Schizophrenia and White Blood Cell Counts Suggest Genetically Determined Systemic Immune Abnormalities

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical